PF-4989216
/ Pfizer
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
August 06, 2017
Retraction: Targeting Small Cell Lung Cancer Harboring PIK3CA Mutation with a Selective Oral PI3K Inhibitor PF-4989216.
(PubMed, Clin Cancer Res)
- No abstract available.
Journal • Biosimilar • Lung Cancer • Oncology • Small Cell Lung Cancer • Solid Tumor
1 to 1
Of
1
Go to page
1